Bio. While i would agree that institutional ownership is different from VC I do not rely on King pontificating about all of these partners lining up. It's all about the art of negotiations, trying to make big pharma feel they are missing out on something.i don't see anyone running to the alter! JMO. Again I hope I am wrong.
Market Data 
Markets 
AI
